Skip to content

Clinical study on the analgesic and emotional regulation effects of electroacupuncture in the treatment of migraine with different durations

Clinical study on the analgesic and emotional regulation effects of electroacupuncture in the treatment of migraine with different durations

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000366
Enrollment
Unknown
Registered
2026-02-13
Start date
2024-03-22
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

Drug group:Take oral flunarizine hydrochloride capsules, 10 mg each time, once a day, before going to bed every night. Continue the treatment for 2 weeks.
15-minute electroacupuncture group:. The patient lies on their back, with the acupuncture site exposed. The operator presses on the acupuncture point to identify the point of pain response. The site i
Fengchi is inserted obliquely towards the tip of the nose at a depth of 15-25 mm
when inserting Guanyu, the patient holds their hand in a half-clenched fist, and the needle is inserted straight at a depth of 12-20 mm
Sanyingjiao is inserted straight at a depth of 10-15 mm. The lifting, inserting, and twisting techniques are used to allow the needle to penetrate and gain qi. For the two groups of acupuncture points
30-minute electro-acupuncture group:30-minute electro-acupuncture group: The needles are left in and energized for 30 minutes, and then the needles are removed after the electro-acupuncture session is

Sponsors

Zhejiang Rehabilitation Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Meet the above diagnostic criteria of migraine without aura; 2. Both sexes, aged between 18 and 65 years old; 3. Migraine attack frequency at least once every 3 months; 4, the effect of drugs and other treatment methods is not obvious or recurrent; 5. Discontinue other migraine drugs without aura for at least 1 week before treatment.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Suffering from serious diseases that affect the study; 2. Patients with consciousness disorders, severe aphasia, dementia, psychosis, infection, bleeding, and allergy; 3. Pregnant and lactating women; 4. Those who are participating in other clinical trials; 5. Nearly 1 week, take medication to prevent migraine attacks.

Design outcomes

Primary

MeasureTime frame
Cerebral hemodynamic indicators;5-HT;

Secondary

MeasureTime frame
short-form of McGill pain questionnaire, SF-MPQ;Hamilton depression rating scale;Total score of TCM syndromes;

Countries

China

Contacts

Public Contactxiaoqin Le

Zhejiang Rehabilitation Medical Center

365703832@qq.com17764564535

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026